These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8519503)

  • 1. The molecular basis of hereditary skeletal disorders.
    Hästbacka J
    Ann Med; 1995 Aug; 27(4):433-4. PubMed ID: 8519503
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype phenotype correlation in achondroplasia and hypochondroplasia.
    Matsui Y; Yasui N; Kimura T; Tsumaki N; Kawabata H; Ochi T
    J Bone Joint Surg Br; 1998 Nov; 80(6):1052-6. PubMed ID: 9853502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
    Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
    South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast-growth-factor receptor mutations in human skeletal disorders.
    Muenke M; Schell U
    Trends Genet; 1995 Aug; 11(8):308-13. PubMed ID: 8585128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical achondroplasia.
    Gorlin RJ
    Am J Med Genet; 1997 May; 70(2):202; author reply 203-5. PubMed ID: 9128943
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging of Skeletal Disorders Caused by Fibroblast Growth Factor Receptor Gene Mutations.
    Sargar KM; Singh AK; Kao SC
    Radiographics; 2017 Oct; 37(6):1813-1830. PubMed ID: 29019756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibroblast growth factor receptors and hereditary abnormalities of bone growth].
    Bonaventure J; Rousseau F; Legeai-Mallet L; Benoist-Lasselin C; Le Merrer M; Munnich A
    Arch Pediatr; 1997; 4(2 Suppl 2):112s-117s. PubMed ID: 9246316
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
    Vajo Z; Francomano CA; Wilkin DJ
    Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
    Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
    Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.
    Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C
    Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM; Losekoot M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
    Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
    Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
    Webster MK; Donoghue DJ
    EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibroblast growth factor receptor and achondroplasia].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1888-93. PubMed ID: 17079857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)].
    Rousseau F; Bonaventure J; Le Merrer M; Munnich A
    Ann Endocrinol (Paris); 1996; 57(3):151-2. PubMed ID: 8949407
    [No Abstract]   [Full Text] [Related]  

  • 17. Achondroplasia and nail-patella syndrome: the compound phenotype.
    Wright MJ; Ain MC; Clough MV; Bellus GA; Hurko O; McIntosh I
    J Med Genet; 2000 Sep; 37(9):E25. PubMed ID: 10978372
    [No Abstract]   [Full Text] [Related]  

  • 18. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
    Superti-Furga A; Eich G; Bucher HU; Wisser J; Giedion A; Gitzelmann R; Steinmann B
    Eur J Pediatr; 1995 Mar; 154(3):215-9. PubMed ID: 7758520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
    Naski MC; Wang Q; Xu J; Ornitz DM
    Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
    Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
    Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.